Related Experiment Video

Updated: May 29, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

Minimally invasive mitral valve surgery expands the surgical options for high-risks patients

Michael R Petracek1, Marzia Leacche, Natalia Solenkova

  • 1Vanderbilt Heart and Vascular Institute, Nashville, TN, USA.

Annals of Surgery
|September 28, 2011
PubMed
Abstract

Insights

Minimally invasive mitral valve surgery (MIMVS) without aortic cross-clamping offers a safe and effective alternative, especially for high-risk patients. This approach demonstrates lower-than-predicted mortality and morbidity compared to traditional methods.

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Techniques
  • Surgical Outcomes

Background:

  • A novel simplified minimally invasive mitral valve surgery (MIMVS) was developed, utilizing a small incision and avoiding aortic cross-clamping and cardioplegic arrest.
  • The approach was hypothesized to offer superior outcomes in high-risk patients and those with prior sternotomy compared to standard median sternotomy procedures.

Purpose of the Study:

  • To evaluate the safety and efficacy of MIMVS without aortic cross-clamp.
  • To compare MIMVS outcomes against predicted results from the Society of Thoracic Surgeons (STS) algorithm for standard mitral valve surgery.

Main Methods:

  • 504 consecutive patients underwent MIMVS between January 2006 and August 2009.
  • Procedures included mitral valve repair (44%) or replacement (56%) under cold fibrillatory arrest without aortic cross-clamp.
  • Patient data included demographics, preoperative New York Heart Association class, ejection fraction, and STS predicted mortality.

Main Results:

  • Overall 30-day mortality was 2.2% (11/504).
  • For high-risk patients (STS predicted mortality ≥10%), observed 30-day mortality was 4% (2/47), significantly lower than the predicted 20%.
  • Morbidity in high-risk patients was low, with minimal reexploration, neurologic deficit, or wound infection. Median length of stay was 8 days.

Conclusions:

  • MIMVS without aortic cross-clamp is a reproducible technique with low mortality and morbidity.
  • This approach provides a valuable surgical option for high-risk patients.
  • MIMVS demonstrates superior results compared to conventional median sternotomy for mitral valve surgery.

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...